Location : Home > About BMS > Departments

Department of Pathogen Biology and Microbiology

Edit:0916032 Date:2018-03-27

Basic Information

Department of Pathogen Biology and Microbiology at Zhejiang University School of Medicine currently has twenty faculty members, including ten professors (research fellow) / PhD and MD supervisors, eight associate professors (associate research fellow) / master supervisors, and two lecturers. All these faculty members have doctoral degrees. Among the faculty members, two of them have received Special National Government Allowance of China, three are the members of the Young Thousand Talents of China, one is the Qiushi distinguished professor of ZhejiangUniversity and one is the Guangbiao lecture professor of ZhejiangUniversity. The department is the member of CollaborativeInnovationCenter for Diagnosis and Treatment of Infectious Diseases of China. Moreover, the department contains the Division of Basic Medical Microbiology of Chinese State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the Zhejiang Provincial Key Laboratory of Microbiological Biochemistry and Metabolic Engineering, the Zhejiang Provincial Engineering Laboratory of Microbiological Pharmacy and the Research Institute of Pharmaceutical Biotechnology of Zhejiang University.

Featured Research

In the recent years, the department has obtained nearly one hundred research grants from the Key Program of the National Natural Science Foundation of China, the National 863 Programs of China, the National Science and Technology Major Projects of China for New Drug Innovation and Development, the General Program of the National Natural Science Foundation of China, the National 973 Programs of China (sub-grant), the National Science and Technology Major Projects of China for Infectious Diseases (sub-grant), the Zhejiang Provincial Natural Science Foundation of China and the Cooperation Programs from many enterprises. The faculty members have published over 500 papers in SCI- listed journals, obtained 2 first grade and 7 second grade prizes of the Provincial or Scientific and Technique Achievement Awards of China and over 30 Chinese National Invention Patents as well as several Chinese national new drug certificates and Chinese national key new products produced by bacteria. At the present, the department has 9 principle investigator (PI) groups in many research fields including molecular pathogenic mechanism and novel vaccines of human-animal-infected microbes, molecular pathogenic mechanism and novel vaccines of sexually transmitted pathogens, molecular mechanisms of bacterial drug resistance and bacterial membrane-associated pathogenicity, molecular pathogenic mechanism and novel antiviral drugs of herpes viruses, microbial synthetic biology, microbe-derived drug production engineering, microbial bioinformatics and combinatorial drug design, microbial biocatalysis and biotransformation.

Teaching Characteristics

The courses for Chinese undergraduate students: Medical Midcrobiology and Medical Parasitology as well as Biochemistry, Biochip principle and data analysis, experiments of life science and technology. The courses for international undergraduate students: Medical Microbiology and Medical Parasitology. The courses for postgraduate students: Molecular Pathogen Biology, Special Topic in Pathogen Biology and Cell Culture Technique as well as Advance in Microbial Synthetic Biology, Advance in Microbial Bioinformatics and Advance in Microbiological Technique for Drug Production.

Directions of Graduate Education

The research fields: a) Molecular pathogenic mechanism and novel vaccine development of human-animal-infected microbes; b) Molecular pathogenic mechanism and novel vaccine development of sexually transmitted pathogens, c) Molecular mechanisms of bacterial drug resistance and bacterial membrane-associated pathogenicity; d) Molecular pathogenic mechanism and novel antiviral drug development of herpes viruses; e) Microbial synthetic biology; f) Microbe-derived drug production; g) Microbial bioinformatics and combinatorial drug design; h) Microbial biocatalysis and biotransformation.